RE:RE:RE:RE:RE:RE:Looking for help w/numbers for burn rate, cash on hand, et.We seem to be in a better place than is suggested by the market following recent positive announcements though it may take the next Quarterly to confirm what many of us were hoping and are now at least to a degree beginning to anticipate from results for those in Phase II who have received optimal treatment ab initio.
There have been a few wobbles - maybe only to be expected with a new drug and a new activation device - but there is now the tantalising prospect that TLD-1433 may henceforth perform in line with our high expectations in NMIBC and that Rutherrin may be used to humanely and effectively treat some of the worst and most difficult cancers before the end of next year.
Given up waiting for the OSC to clean up this market - the sooner TLT gets off the Venture the better.